See more : NEOJAPAN Inc. (3921.T) Income Statement Analysis – Financial Results
Complete financial analysis of Encompass Health Corporation (EHC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Encompass Health Corporation, a leading company in the Medical – Care Facilities industry within the Healthcare sector.
You may be interested
- Sarepta Therapeutics, Inc. (0L35.L) Income Statement Analysis – Financial Results
- MiTAC Holdings Corporation (3706.TW) Income Statement Analysis – Financial Results
- PSP Swiss Property AG (PSPSF) Income Statement Analysis – Financial Results
- Marusan Securities Co., Ltd. (8613.T) Income Statement Analysis – Financial Results
- Global Medical REIT Inc. (GMRE) Income Statement Analysis – Financial Results
Encompass Health Corporation (EHC)
About Encompass Health Corporation
Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates in two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment provides home health and hospice services primarily in the Southeast and Texas. Its home health services include a range of Medicare-certified home nursing services to adult patients in need of care comprising skilled nursing, medical social work, and home health aide services, as well as physical, occupational, speech therapy, and others. This segment's hospice services comprise in-home services to terminally ill patients and their families. As of June 1, 2022, it operated 149 hospitals, 252 home health locations, and 99 hospice locations in 42 states and Puerto Rico. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was founded in 1983 and is based in Birmingham, Alabama.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 | 1985 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.80B | 4.35B | 5.12B | 4.64B | 4.61B | 4.28B | 3.92B | 3.65B | 3.12B | 2.37B | 2.25B | 2.13B | 2.03B | 520.70M | 1.91B | 1.84B | 1.75B | 3.00B | 3.21B | 3.75B | 3.96B | 4.31B | 4.38B | 4.20B | 4.07B | 4.01B | 3.02B | 2.44B | 1.56B | 1.13B | 482.30M | 407.00M | 225.50M | 180.50M | 114.20M | 75.00M | 45.00M | 18.60M | 4.50M |
| Cost of Revenue | 3.87B | 202.10M | 209.30M | 200.50M | 167.90M | 158.70M | 149.30M | 140.00M | 128.70M | 111.90M | 105.40M | 102.40M | 1.31B | 0.00 | 1.33B | 108.90M | 969.80M | 1.69B | 1.73B | 2.46B | 2.58B | 3.09B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 348.90M | 313.80M | 165.60M | 135.80M | 85.20M | 55.70M | 33.60M | 14.10M | 4.10M |
| Gross Profit | 933.50M | 4.15B | 4.91B | 4.44B | 4.44B | 4.12B | 3.77B | 3.51B | 2.99B | 2.26B | 2.14B | 2.03B | 712.50M | 520.70M | 578.50M | 1.73B | 782.70M | 1.31B | 1.48B | 1.29B | 1.38B | 1.22B | 4.38B | 4.20B | 4.07B | 4.01B | 3.02B | 2.44B | 1.56B | 1.13B | 133.40M | 93.20M | 59.90M | 44.70M | 29.00M | 19.30M | 11.40M | 4.50M | 400.00K |
| Gross Profit Ratio | 19.44% | 95.35% | 95.91% | 95.68% | 96.35% | 96.29% | 96.19% | 96.16% | 95.87% | 95.29% | 95.31% | 95.20% | 35.15% | 100.00% | 30.27% | 94.09% | 44.66% | 43.80% | 46.15% | 34.43% | 34.80% | 28.25% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 27.66% | 22.90% | 26.56% | 24.76% | 25.39% | 25.73% | 25.33% | 24.19% | 8.89% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 201.70M | 2.60B | 3.16B | 2.92B | 2.90B | 2.65B | 2.40B | 2.19B | 1.86B | 1.34B | 1.27B | 1.23B | 1.25B | 327.00M | 1.21B | 149.90M | 186.40M | 235.60M | 246.18M | 289.75M | 157.93M | 0.00 | 167.21M | 148.02M | 149.29M | 112.80M | 82.76M | 66.81M | 42.51M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -1.01B | 1.28B | 330.10M | 717.90M | 616.28M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 201.70M | 2.60B | 3.16B | 2.92B | 2.90B | 2.65B | 2.40B | 2.19B | 1.86B | 1.34B | 1.27B | 1.23B | 1.25B | 327.00M | 197.60M | 1.43B | 516.50M | 953.50M | 862.45M | 289.75M | 157.93M | 304.44M | 167.21M | 148.02M | 149.29M | 112.80M | 82.76M | 66.81M | 42.51M | 37.14M | 26.70M | 11.00M | 5.30M | 5.10M | 4.90M | 3.60M | 2.20M | 1.80M | 1.70M |
| Other Expenses | 0.00 | 914.00M | 941.80M | 877.40M | 842.30M | 2.20M | 4.10M | 2.90M | 5.50M | 31.20M | 4.50M | 8.50M | 99.80M | 387.70M | 378.90M | 83.80M | 77.50M | 148.20M | 167.11M | 3.52B | 4.10B | 0.00 | 2.74B | 2.67B | 2.54B | 2.38B | 1.81B | 1.59B | 1.09B | 0.00 | 36.50M | 25.50M | 14.70M | 11.10M | 7.10M | 4.00M | 2.60M | 1.20M | 400.00K |
| Operating Expenses | 693.90M | 3.52B | 4.11B | 3.80B | 3.74B | 3.44B | 3.12B | 2.86B | 2.43B | 1.80B | 1.68B | 1.62B | 1.35B | 426.60M | 305.10M | 1.51B | 594.00M | 1.10B | 1.03B | 3.52B | 4.10B | 304.44M | 2.91B | 2.82B | 2.69B | 2.49B | 1.89B | 1.65B | 1.13B | 873.03M | 63.20M | 36.50M | 20.00M | 16.20M | 12.00M | 7.60M | 4.80M | 3.00M | 2.10M |
| Cost & Expenses | 4.07B | 3.72B | 4.32B | 4.00B | 3.91B | 3.60B | 3.27B | 3.00B | 2.56B | 1.91B | 1.79B | 1.72B | 1.35B | 426.60M | 1.64B | 1.62B | 1.56B | 2.79B | 2.76B | 3.52B | 4.10B | 3.40B | 2.91B | 2.82B | 2.69B | 2.49B | 1.89B | 1.65B | 1.13B | 873.03M | 412.10M | 350.30M | 185.60M | 152.00M | 97.20M | 63.30M | 38.40M | 17.10M | 6.20M |
| Interest Income | 0.00 | 175.70M | 164.30M | 183.70M | 159.70M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 143.50M | 175.70M | 164.60M | 184.20M | 159.70M | 147.30M | 154.40M | 172.10M | 142.90M | 109.20M | 100.40M | 94.10M | 119.40M | 34.50M | 125.80M | 159.70M | 229.90M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 273.90M | 243.60M | 219.60M | 243.00M | 218.70M | 199.70M | 183.80M | 172.60M | 139.70M | 107.70M | 94.70M | 82.50M | 78.80M | 76.40M | 70.90M | 97.00M | 85.30M | 166.50M | 208.13M | 199.49M | 200.20M | 205.70M | 375.27M | 360.85M | 374.25M | 344.59M | 250.01M | 188.97M | 121.20M | 75.59M | -36.50M | -25.50M | -14.70M | -11.10M | -7.10M | 4.00M | 2.60M | 1.20M | 400.00K |
| EBITDA | 1.02B | 873.80M | 879.00M | 815.20M | 911.20M | 881.30M | 833.20M | 823.80M | 709.20M | 592.00M | 553.50M | 516.60M | 441.10M | 406.20M | 320.20M | 437.40M | 273.30M | 173.10M | 232.60M | 488.82M | -8.34M | 3.73B | 1.85B | 3.45B | 1.76B | 1.86B | 1.01B | 785.80M | 547.81M | 330.00M | 106.70M | 81.50M | 49.10M | 35.50M | 20.00M | 15.70M | 9.20M | 2.70M | -1.30M |
| EBITDA Ratio | 21.34% | 20.04% | 21.08% | 19.48% | 20.60% | 20.86% | 21.57% | 22.88% | 22.73% | 25.92% | 25.33% | 24.22% | 37.77% | 33.24% | 18.26% | 10.41% | 19.13% | 25.28% | 33.22% | 13.02% | 4.86% | 37.60% | 42.25% | 41.47% | 43.16% | 46.40% | 45.70% | 39.92% | 35.19% | 29.27% | 31.76% | 20.02% | 21.77% | 19.67% | 17.51% | 18.27% | 17.56% | 11.83% | -35.56% |
| Operating Income | 731.80M | 627.90M | 822.80M | 661.90M | 729.70M | 681.60M | 649.40M | 648.80M | 554.20M | 465.70M | 381.90M | 413.40M | 674.70M | 342.20M | 273.40M | 219.20M | 188.70M | 212.20M | 450.75M | 233.12M | -140.43M | 913.20M | 1.48B | 1.38B | 1.38B | 1.51B | 1.13B | 783.73M | 426.62M | 254.41M | 70.20M | 56.70M | 39.90M | 28.50M | 17.00M | 11.70M | 6.60M | 1.50M | -1.70M |
| Operating Income Ratio | 15.24% | 14.44% | 16.07% | 14.25% | 15.85% | 15.94% | 16.57% | 17.79% | 17.79% | 19.61% | 16.99% | 19.36% | 33.29% | 65.72% | 14.31% | 11.90% | 10.77% | 7.07% | 14.05% | 6.21% | -3.55% | 21.18% | 33.68% | 32.87% | 33.97% | 37.80% | 37.41% | 32.17% | 27.41% | 22.57% | 14.56% | 13.93% | 17.69% | 15.79% | 14.89% | 15.60% | 14.67% | 8.06% | -37.78% |
| Total Other Income/Expenses | -124.60M | -1.09B | -969.90M | 103.80M | -130.20M | -188.40M | -153.00M | -166.80M | -158.60M | -78.80M | -63.60M | -73.40M | -140.70M | -137.90M | -153.40M | -23.70M | -312.80M | -582.60M | -448.89M | -375.12M | -358.36M | -1.28B | -1.64B | -1.81B | -1.15B | -1.25B | -194.80M | -227.50M | -214.30M | -167.15M | -59.40M | -11.70M | -6.00M | -8.40M | -4.50M | -2.80M | -400.00K | -500.00K | 300.00K |
| Income Before Tax | 607.20M | 450.80M | 657.20M | 472.60M | 562.30M | 493.20M | 496.40M | 482.00M | 395.60M | 386.90M | 395.20M | 340.00M | 242.90M | 50.80M | 123.50M | 164.70M | -123.60M | -557.90M | -344.79M | -141.99M | -498.79M | -242.14M | 433.73M | 559.35M | 229.92M | 267.37M | 601.63M | 410.49M | 142.62M | 87.26M | 10.80M | 45.00M | 33.90M | 20.10M | 12.50M | 8.90M | 6.20M | 1.00M | -1.40M |
| Income Before Tax Ratio | 12.65% | 10.37% | 12.83% | 10.18% | 12.21% | 11.53% | 12.67% | 13.22% | 12.70% | 16.30% | 17.59% | 15.93% | 11.98% | 9.76% | 6.46% | 8.94% | -7.05% | -18.60% | -10.75% | -3.78% | -12.60% | -5.62% | 9.90% | 13.33% | 5.65% | 6.67% | 19.94% | 16.85% | 9.16% | 7.74% | 2.24% | 11.06% | 15.03% | 11.14% | 10.95% | 11.87% | 13.78% | 5.38% | -31.11% |
| Income Tax Expense | 132.20M | 100.10M | 139.60M | 103.80M | 115.90M | 118.90M | 160.60M | 163.90M | 141.90M | 110.70M | 12.70M | 108.60M | 37.10M | -736.20M | -3.20M | -70.10M | -322.40M | 41.10M | 39.79M | 11.91M | -42.42M | -55.21M | 139.47M | 181.81M | 66.93M | 143.35M | 206.15M | 140.24M | 48.09M | 33.84M | 4.10M | 15.30M | 11.50M | 7.20M | 4.40M | 3.20M | 2.40M | 500.00K | -200.00K |
| Net Income | 352.00M | 271.00M | 412.20M | 284.20M | 358.70M | 292.30M | 256.30M | 247.60M | 183.10M | 222.00M | 323.60M | 185.00M | 208.70M | 779.20M | 94.80M | 252.40M | 653.40M | -625.00M | -445.99M | -174.47M | -434.56M | -270.09M | 202.39M | 278.47M | 76.52M | 46.56M | 330.61M | 220.82M | 78.95M | 53.23M | 6.70M | 29.70M | 22.40M | 12.90M | 8.10M | 5.70M | 3.80M | 500.00K | -1.50M |
| Net Income Ratio | 7.33% | 6.23% | 8.05% | 6.12% | 7.79% | 6.83% | 6.54% | 6.79% | 5.88% | 9.35% | 14.40% | 8.67% | 10.30% | 149.64% | 4.96% | 13.70% | 37.28% | -20.83% | -13.90% | -4.65% | -10.98% | -6.27% | 4.62% | 6.64% | 1.88% | 1.16% | 10.96% | 9.06% | 5.07% | 4.72% | 1.39% | 7.30% | 9.93% | 7.15% | 7.09% | 7.60% | 8.44% | 2.69% | -33.33% |
| EPS | 3.54 | 2.72 | 4.15 | 2.87 | 3.65 | 2.99 | 2.73 | 2.77 | 2.02 | 2.46 | 2.58 | 1.67 | 1.91 | 9.41 | 0.77 | 2.73 | 7.97 | -7.86 | -5.62 | -2.20 | -5.49 | -3.41 | -2.45 | -4.70 | 0.95 | 0.55 | 5.22 | 3.23 | 3.45 | 1.75 | 0.24 | 1.04 | 0.79 | 0.45 | 0.28 | 0.20 | 0.13 | 0.02 | -0.05 |
| EPS Diluted | 3.47 | 2.70 | 4.11 | 2.85 | 3.61 | 2.93 | 2.69 | 2.59 | 1.91 | 2.29 | 2.58 | 1.67 | 1.91 | 8.28 | 0.77 | 2.62 | 7.10 | -6.92 | -5.60 | -2.19 | -5.35 | -3.31 | -2.45 | -4.70 | 0.90 | 0.55 | 5.22 | 3.23 | 3.45 | 1.74 | 0.24 | 1.04 | 0.79 | 0.45 | 0.28 | 0.20 | 0.13 | 0.02 | -0.05 |
| Weighted Avg Shares Out | 99.50M | 99.20M | 99.00M | 98.60M | 98.00M | 97.90M | 93.70M | 89.10M | 89.40M | 86.80M | 88.10M | 94.60M | 93.30M | 92.80M | 88.80M | 83.00M | 78.70M | 79.50M | 79.30M | 79.28M | 79.23M | 79.10M | 78.10M | 77.33M | 81.64M | 84.29M | 79.66M | 65.77M | 60.99M | 30.35M | 28.45M | 28.45M | 28.45M | 28.45M | 28.45M | 28.45M | 28.45M | 28.45M | 28.45M |
| Weighted Avg Shares Out (Dil) | 101.30M | 100.40M | 100.20M | 99.80M | 99.40M | 99.80M | 99.30M | 99.50M | 101.00M | 100.70M | 102.10M | 108.10M | 109.20M | 108.50M | 103.30M | 96.40M | 92.00M | 90.30M | 79.60M | 79.53M | 81.17M | 81.70M | 83.03M | 78.28M | 82.91M | 86.46M | 79.66M | 65.77M | 60.99M | 30.63M | 28.45M | 28.45M | 28.45M | 28.45M | 28.45M | 28.45M | 28.45M | 28.45M | 28.45M |
Here's Why Encompass Health (EHC) is a Strong Growth Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Delaware Court of Chancery Awards Damages and Other Relief to Encompass Health and Enhabit for Misconduct by April Anthony, Other Former Officers, and Private Equity Firms Vistria Group and Nautic Partners
BIRMINGHAM, Ala., and DALLAS , Dec. 4, 2024 /PRNewswire/ -- On Monday, Encompass Health and Enhabit won their lawsuit in the Delaware Court of Chancery related to breaches of fiduciary duty by April Anthony, Luke James, and Chris Walker while they...
Delaware Court of Chancery Awards Damages and Other Relief to Encompass Health and Enhabit for Misconduct by April Anthony, Other Former Officers, and Private Equity Firms Vistria Group and Nautic Partners
BIRMINGHAM, Ala. & DALLAS--(BUSINESS WIRE)--On Monday, Encompass Health and Enhabit won their lawsuit in the Delaware Court of Chancery related to breaches of fiduciary duty by April Anthony, Luke James, and Chris Walker while they served as the senior officers...
Encompass Health Up 60% in a Year: What Lies Ahead for Investors?
EHC remains well-poised for growth on the back of solid discharge growth, an aging U.S. population, frequent expansion initiatives and strong cash reserves.
Why Is Encompass Health (EHC) Up 3.8% Since Last Earnings Report?
Encompass Health (EHC) reported earnings 30 days ago. What's next for the stock?
Are Investors Undervaluing Encompass Health (EHC) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong...
EHC vs. CHE: Which Stock Is the Better Value Option?
Investors interested in stocks from the Medical - Outpatient and Home Healthcare sector have probably already heard of Encompass Health (EHC) and Chemed (CHE). But which of these two stocks presents investors with the better value opportunity right now?
Why Encompass Health (EHC) is a Top Growth Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Encompass Health Rehabilitation Hospital of Houston at The Medical Center Now Open in Texas
The 61-bed inpatient rehabilitation hospital is Encompass Health's first hospital fully constructed using prefabricated modules. BIRMINGHAM, Ala.
Should Value Investors Buy Encompass Health (EHC) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong...
Source: https://incomestatements.info
Category: Stock Reports